| # | Drug | Count |
|---|---|---|
| 0 | LANSOPRAZOLE | 10 |
| 1 | PREDNISOLONE | 8 |
| 2 | PREDNISOLONE ORAL | 8 |
| 3 | PREDNISOLONE ORAL SOLUTION | 8 |
| 4 | AZATHIOPRINE | 6 |
| 5 | ZINC | 6 |
| 6 | ZINC CHLORIDE | 6 |
| 7 | ZINC GLUCONATE | 6 |
| 8 | ACETAMINOPHEN | 5 |
| 9 | ACETAMINOPHEN 500MG | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LUSUTROMBOPAG | 1 | 0.0256 |
| 1 | PROBENECID AND COLCHICINE | 1 | 0.0098 |
| 2 | VADADUSTAT | 1 | 0.0033 |
| 3 | IBUPROFEN LYSINE | 1 | 0.0018 |
| 4 | DORAVIRINE | 1 | 0.0013 |
| 5 | DEXCHLORPHENIRAMINE MALEATE | 1 | 0.0010 |
| 6 | PIOGLITAZONE HYDROCHLORIDE | 1 | 0.0008 |
| 7 | ZOLBETUXIMAB | 1 | 0.0007 |
| 8 | INFLIXIMAB-DYYB | 2 | 0.0006 |
| 9 | LEVOCARNITINE | 2 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 1 | Carnitine Analog [EPC] | 2 | 0.0005 |
| 2 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 2 | 0.0005 |
| 3 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 4 | Melatonin Receptor Agonist [EPC] | 3 | 0.0002 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 6 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 7 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Nonergot Dopamine Agonist [EPC] | 2 | 0.0001 |
| 9 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |